Pseudoscience at the expense of rheumatic disease patients during the Coronavirus disease 2019 pandemic

Simple item page
dc.contributor.authorAkkoc N.
dc.date.accessioned2024-07-22T08:06:35Z
dc.date.available2024-07-22T08:06:35Z
dc.date.issued2021
dc.description.abstract[No abstract available]
dc.identifier.issn0392856X
dc.identifier.urihttp://akademikarsiv.cbu.edu.tr:4000/handle/123456789/13599
dc.language.isoEnglish
dc.publisherClinical and Experimental Rheumatology S.A.S.
dc.subjectCOVID-19
dc.subjectHumans
dc.subjectPandemics
dc.subjectPseudoscience
dc.subjectRheumatic Diseases
dc.subjectSARS-CoV-2
dc.subjectazithromycin
dc.subjectchloroquine
dc.subjecthydroxychloroquine
dc.subjectChina
dc.subjectcoronavirus disease 2019
dc.subjectdrug efficacy
dc.subjectfollow up
dc.subjectFrance
dc.subjecthuman
dc.subjectLetter
dc.subjectlong term survival
dc.subjectnasopharyngeal swab
dc.subjectpandemic
dc.subjectpersonal experience
dc.subjectpolymerase chain reaction
dc.subjectpseudoscience
dc.subjectrheumatic disease
dc.subjectrheumatoid arthritis
dc.subjectsystemic lupus erythematosus
dc.subjectviral clearance
dc.subjectpandemic
dc.subjectrheumatic disease
dc.titlePseudoscience at the expense of rheumatic disease patients during the Coronavirus disease 2019 pandemic
dc.typeLetter

Files

Collections

Scopus Koleksiyonu